MZ

Mohammed Zuraid Mulla

Active Director Additional Director DIN 11348454
DIN 11348454 First appointment Oct 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammed Zuraid Mulla

Data last updated:

Mohammed Zuraid Mulla is an Additional Director at Zengenic Pharmaceuticals India Private Limited (since 2025). The company operates in Paper.

DIN 11348454
Primary Designation Additional Director
Industry Paper
First Appointment 20 Oct 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director20 Oct 2025Active

Board colleagues of Mohammed Zuraid Mulla

Directorship timeline

Open interactive timeline →
Zengenic Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Mohammed Zuraid Mulla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammed Zuraid Mulla

Mohammed Zuraid Mulla currently holds 1 directorship: Zengenic Pharmaceuticals India Private Limited (Additional Director, since 20 Oct 2025).

Mohammed Zuraid Mulla was first appointed on 20 Oct 2025 as Additional Director at Zengenic Pharmaceuticals India Private Limited.

The current boards of Mohammed Zuraid Mulla's companies include Kalyani K Karekar (Zengenic Pharmaceuticals India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available